CytoImmune Therapeutics Appoints Yulii Bogatyrenko as Chief Business Officer and Expands the Board of Directors with the Appointment of Graeme Bell
DUARTE, Calif.–(BUSINESS WIRE)–CytoImmune Therapeutics, a clinical-stage immuno-oncology company that is developing a novel class of…